Appili Common Stock Shares Outstanding vs Capital Surpluse Analysis

APLI Stock

CAD 0.03 0.01 14.29%

Appili Therapeutics financial indicator trend analysis is way more than just evaluating Appili Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Appili Therapeutics is a good investment. Please check the relationship between Appili Therapeutics Common Stock Shares Outstanding and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Appili Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Common Stock Shares Outstanding vs Capital Surpluse

Common Stock Shares Outstanding vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Appili Therapeutics Common Stock Shares Outstanding account and Capital Surpluse. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Appili Therapeutics' Common Stock Shares Outstanding and Capital Surpluse is 0.97. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Appili Therapeutics, assuming nothing else is changed. The correlation between historical values of Appili Therapeutics' Common Stock Shares Outstanding and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Appili Therapeutics are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Common Stock Shares Outstanding i.e., Appili Therapeutics' Common Stock Shares Outstanding and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Capital Surpluse

Most indicators from Appili Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Appili Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Appili Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Appili Therapeutics' Tax Provision is very stable compared to the past year. As of the 9th of January 2025, Enterprise Value is likely to grow to about 22.5 M, while Selling General Administrative is likely to drop about 3.5 M.

	2023	2024	2025 (projected)
Total Operating Expenses	8.8M	10.2M	10.8M
Cost Of Revenue	13.7K	12.3K	11.2K

Total Operating Expenses Cost Of Revenue

Appili Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		-0.28	-0.25	-0.15	0.72	0.81	0.37	-0.32	-0.77	0.03	0.31	0.96	0.37	-0.41	0.28	0.08	1.0	0.28	-0.23	-0.28	0.08	-0.1	0.66	-0.43	-0.11	1.0
Short Long Term Debt Total	-0.28		-0.66	0.91	-0.84	-0.67	-0.7	0.13	0.81	-0.94	0.69	-0.3	-0.7	0.91	-0.68	0.44	-0.29	-0.19	0.98	1.0	0.44	0.98	0.36	0.91	0.97	-0.28
Other Current Liab	-0.25	-0.66		-0.67	0.34	0.15	0.47	-0.42	-0.27	0.76	-0.7	-0.24	0.47	-0.58	0.39	-0.35	-0.25	0.19	-0.66	-0.66	-0.35	-0.76	-0.8	-0.51	-0.72	-0.25
Total Current Liabilities	-0.15	0.91	-0.67		-0.71	-0.51	-0.54	0.19	0.71	-0.85	0.74	-0.23	-0.54	0.84	-0.75	0.11	-0.17	0.08	0.92	0.9	0.11	0.9	0.43	0.88	0.93	-0.15
Total Stockholder Equity	0.72	-0.84	0.34	-0.71		0.95	0.73	-0.27	-0.97	0.71	-0.4	0.72	0.73	-0.85	0.52	-0.33	0.73	0.19	-0.79	-0.85	-0.33	-0.74	0.11	-0.9	-0.75	0.72
Net Tangible Assets	0.81	-0.67	0.15	-0.51	0.95		0.66	-0.27	-0.9	0.53	-0.27	0.77	0.66	-0.69	0.4	-0.36	0.81	0.17	-0.58	-0.68	-0.36	-0.56	0.32	-0.82	-0.58	0.8
Property Plant And Equipment Net	0.37	-0.7	0.47	-0.54	0.73	0.66		-0.52	-0.7	0.72	-0.5	0.43	1.0	-0.87	0.27	-0.51	0.36	0.17	-0.71	-0.71	-0.51	-0.69	-0.19	-0.62	-0.67	0.37
Current Deferred Revenue	-0.32	0.13	-0.42	0.19	-0.27	-0.27	-0.52		0.31	-0.1	0.01	-0.37	-0.52	0.41	-0.19	-0.17	-0.32	-0.15	0.16	0.12	-0.17	0.13	0.13	0.14	0.11	-0.32
Net Debt	-0.77	0.81	-0.27	0.71	-0.97	-0.9	-0.7	0.31		-0.63	0.29	-0.8	-0.7	0.85	-0.62	0.18	-0.78	-0.17	0.79	0.81	0.18	0.69	-0.11	0.84	0.7	-0.76
Retained Earnings	0.03	-0.94	0.76	-0.85	0.71	0.53	0.72	-0.1	-0.63		-0.84	0.06	0.72	-0.84	0.48	-0.58	0.03	0.09	-0.93	-0.95	-0.58	-0.98	-0.54	-0.84	-0.97	0.02
Accounts Payable	0.31	0.69	-0.7	0.74	-0.4	-0.27	-0.5	0.01	0.29	-0.84		0.24	-0.5	0.56	-0.29	0.48	0.28	0.33	0.68	0.69	0.48	0.78	0.62	0.69	0.83	0.31
Cash	0.96	-0.3	-0.24	-0.23	0.72	0.77	0.43	-0.37	-0.8	0.06	0.24		0.43	-0.46	0.32	0.15	0.97	0.08	-0.28	-0.3	0.15	-0.13	0.56	-0.44	-0.15	0.96
Non Current Assets Total	0.37	-0.7	0.47	-0.54	0.73	0.66	1.0	-0.52	-0.7	0.72	-0.5	0.43		-0.87	0.27	-0.51	0.36	0.17	-0.71	-0.71	-0.51	-0.69	-0.19	-0.62	-0.67	0.37
Non Currrent Assets Other	-0.41	0.91	-0.58	0.84	-0.85	-0.69	-0.87	0.41	0.85	-0.84	0.56	-0.46	-0.87		-0.62	0.29	-0.41	-0.19	0.92	0.9	0.29	0.87	0.25	0.82	0.86	-0.41
Other Assets	0.28	-0.68	0.39	-0.75	0.52	0.4	0.27	-0.19	-0.62	0.48	-0.29	0.32	0.27	-0.62		0.08	0.29	0.15	-0.71	-0.66	0.08	-0.63	-0.22	-0.64	-0.65	0.28
Long Term Debt	0.08	0.44	-0.35	0.11	-0.33	-0.36	-0.51	-0.17	0.18	-0.58	0.48	0.15	-0.51	0.29	0.08		0.1	-0.29	0.37	0.47	1.0	0.5	0.26	0.34	0.46	0.09
Cash And Short Term Investments	1.0	-0.29	-0.25	-0.17	0.73	0.81	0.36	-0.32	-0.78	0.03	0.28	0.97	0.36	-0.41	0.29	0.1		0.22	-0.23	-0.28	0.1	-0.1	0.65	-0.44	-0.12	1.0
Net Receivables	0.28	-0.19	0.19	0.08	0.19	0.17	0.17	-0.15	-0.17	0.09	0.33	0.08	0.17	-0.19	0.15	-0.29	0.22		-0.14	-0.2	-0.29	-0.16	0.09	0.01	-0.03	0.28
Common Stock Shares Outstanding	-0.23	0.98	-0.66	0.92	-0.79	-0.58	-0.71	0.16	0.79	-0.93	0.68	-0.28	-0.71	0.92	-0.71	0.37	-0.23	-0.14		0.98	0.37	0.97	0.44	0.86	0.96	-0.22
Long Term Debt Total	-0.28	1.0	-0.66	0.9	-0.85	-0.68	-0.71	0.12	0.81	-0.95	0.69	-0.3	-0.71	0.9	-0.66	0.47	-0.28	-0.2	0.98		0.47	0.98	0.36	0.91	0.97	-0.28
Non Current Liabilities Total	0.08	0.44	-0.35	0.11	-0.33	-0.36	-0.51	-0.17	0.18	-0.58	0.48	0.15	-0.51	0.29	0.08	1.0	0.1	-0.29	0.37	0.47		0.5	0.26	0.34	0.46	0.09
Capital Surpluse	-0.1	0.98	-0.76	0.9	-0.74	-0.56	-0.69	0.13	0.69	-0.98	0.78	-0.13	-0.69	0.87	-0.63	0.5	-0.1	-0.16	0.97	0.98	0.5		0.52	0.87	0.99	-0.1
Other Current Assets	0.66	0.36	-0.8	0.43	0.11	0.32	-0.19	0.13	-0.11	-0.54	0.62	0.56	-0.19	0.25	-0.22	0.26	0.65	0.09	0.44	0.36	0.26	0.52		0.13	0.48	0.66
Other Stockholder Equity	-0.43	0.91	-0.51	0.88	-0.9	-0.82	-0.62	0.14	0.84	-0.84	0.69	-0.44	-0.62	0.82	-0.64	0.34	-0.44	0.01	0.86	0.91	0.34	0.87	0.13		0.91	-0.42
Total Liab	-0.11	0.97	-0.72	0.93	-0.75	-0.58	-0.67	0.11	0.7	-0.97	0.83	-0.15	-0.67	0.86	-0.65	0.46	-0.12	-0.03	0.96	0.97	0.46	0.99	0.48	0.91		-0.1
Total Current Assets	1.0	-0.28	-0.25	-0.15	0.72	0.8	0.37	-0.32	-0.76	0.02	0.31	0.96	0.37	-0.41	0.28	0.09	1.0	0.28	-0.22	-0.28	0.09	-0.1	0.66	-0.42	-0.1

Click cells to compare fundamentals

Appili Therapeutics Account Relationship Matchups

Appili Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	18.3M	8.3M	3.1M	1.5M	1.3M	1.3M
Short Long Term Debt Total	1.0M	5.0M	7.7M	8.2M	9.4M	9.9M
Other Current Liab	167.6K	117.6K	229.9K	75.8K	68.2K	64.8K
Total Current Liabilities	4.6M	6.7M	3.0M	11.5M	13.3M	13.9M
Total Stockholder Equity	12.8M	(3.3M)	(7.4M)	(10.9M)	(9.8M)	(9.3M)
Net Tangible Assets	4.4M	8.8M	12.8M	(3.3M)	(3.8M)	(3.6M)
Property Plant And Equipment Net	55.0K	42.2K	14.6K	30.1K	27.1K	42.7K
Current Deferred Revenue	(54.5K)	(167.6K)	(188.9K)	47.1K	54.2K	56.9K
Net Debt	(10.0M)	(1.7M)	5.2M	8.1M	9.3M	9.8M
Retained Earnings	(31.0M)	(56.1M)	(65.3M)	(69.1M)	(62.2M)	(59.1M)
Accounts Payable	4.5M	6.5M	2.8M	4.1M	4.7M	3.1M
Cash	11.1M	6.7M	2.5M	94.5K	85.0K	80.8K
Non Current Assets Total	55.0K	42.2K	14.6K	30.1K	27.1K	42.7K
Long Term Debt	947.3K	4.9M	7.6M	875.2K	1.0M	956.2K
Cash And Short Term Investments	16.1M	6.7M	2.5M	94.5K	85.0K	80.8K
Net Receivables	1.7M	1.4M	420.8K	1.2M	1.1M	817.8K
Common Stock Shares Outstanding	59.2M	66.7M	113.7M	121.3M	139.5M	146.4M
Long Term Debt Total	950.5K	947.3K	4.9M	7.6M	8.7M	9.1M
Liabilities And Stockholders Equity	18.3M	8.3M	3.1M	1.5M	1.3M	1.3M
Non Current Liabilities Total	947.3K	4.9M	7.6M	875.2K	1.0M	956.2K
Capital Surpluse	1.8M	2.6M	5.0M	6.4M	7.4M	7.7M
Other Current Assets	451.0K	183.5K	231.1K	192.4K	221.3K	231.3K
Other Stockholder Equity	(4.0M)	13.1M	6.4M	12.9M	14.8M	15.5M
Total Liab	5.6M	11.6M	10.5M	12.4M	14.3M	15.0M
Total Current Assets	18.3M	8.2M	3.1M	1.5M	1.3M	1.2M
Accumulated Other Comprehensive Income	(82.3K)	8.1M	9.2M	3.0M	3.4M	2.8M
Short Term Debt	85.3K	95.6K	113.1K	7.3M	8.4M	8.8M
Common Stock	21.0M	35.0M	39.7M	42.3M	48.7M	28.4M
Property Plant Equipment	63.3K	55.0K	42.2K	14.6K	13.1K	12.5K
Net Invested Capital	13.8M	1.7M	268.4K	(2.7M)	(2.5M)	(2.3M)
Short Long Term Debt	85.3K	95.6K	113.1K	7.3M	8.4M	8.8M
Net Working Capital	13.6M	1.6M	140.6K	(10.1M)	(9.1M)	(8.6M)
Capital Stock	21.0M	35.0M	39.7M	42.3M	48.7M	35.1M
Property Plant And Equipment Gross	137.3K	125.6K	55.5K	82.8K	74.6K	85.1K

Pair Trading with Appili Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.

The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Appili Stock

Balance Sheet is a snapshot of the financial position of Appili Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Appili Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Appili Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Appili currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Appili Common Stock Shares Outstanding vs Capital Surpluse Analysis

Common Stock Shares Outstanding vs Capital Surpluse

Common Stock Shares Outstanding vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Capital Surpluse

Appili Therapeutics fundamental ratios Correlations

Appili Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Appili Therapeutics fundamental ratios Accounts

Pair Trading with Appili Therapeutics

Other Information on Investing in Appili Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Long Term Debt Total	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Liabilities Total	+ 1.0	Long Term Debt
Total Current Assets	+ 1.0	Cash And Short Term Investments

Capital Surpluse	- 0.98	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Net Debt	- 0.97	Total Stockholder Equity
Long Term Debt Total	- 0.95	Retained Earnings
Retained Earnings	- 0.94	Short Long Term Debt Total
Common Stock Shares Outstanding	- 0.93	Retained Earnings